Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').
A patient was admitted with hyperthermia, muscle rigidity, rhabdomyolysis and disseminated intravascular coagulation. He was initially thought to have taken 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), but subsequent toxicology revealed the presence of 3,4-methylenedioxyethamphetamine (MDEA, 'Eve'), its sister drug, in his blood. Subsequent in vitro testing for malignant hyperthermia proved to be negative.
Tehan
B
B
Leeds General Infirmary.
Hardern
R
R
Bodenham
A
A
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives* / Q000506:poisoning; D000328:Adult; D015198:Designer Drugs / Q000506:poisoning*; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011041:Poisoning / Q000628:therapy; D019966:Substance-Related Disorders
D015198:Designer Drugs; D015104:3,4-Methylenedioxyamphetamine; C051800:3,4-methylenedioxyethamphetamine